Press release
Genomics Market to Reach USD 120.89 Bn, Growing at 10.20% CAGR
The Genomics Market is undergoing a major transformation driven by breakthroughs in sequencing technologies, personalized medicine, biomarker development, and computational biology. Valued at USD 45.77 Billion in 2024, the market is expected to grow at a CAGR of 10.20% between 2025 and 2034, reaching approximately USD 120.89 Billion by 2034.
Genomics plays a central role in evolving medical research, pharmaceutical innovation, disease diagnostics, precision treatment, and population-based genetic studies. The integration of next-generation sequencing (NGS), PCR, microarrays, bioinformatics tools, and AI-powered analysis has accelerated genomics applications across drug discovery, reproductive health, oncology, infectious diseases, and clinical diagnostics.
Genomics Market Overview
The genomics field involves studying the full genetic makeup of organisms to understand biological functions, interactions, and disease mechanisms. Demand for genomics has significantly increased across biopharmaceutical companies, diagnostic laboratories, and academic institutions.
Key Market Highlights
Market Size (2024): USD 45.77 Billion
Forecast (2034): USD 120.89 Billion
CAGR (2025-2034): 10.20%
Primary Growth Drivers: Personalized medicine, NGS adoption, biomarker discovery, and rising chronic disease burden
Leading Companies: Illumina, Thermo Fisher Scientific, Danaher, F. Hoffmann-La Roche, QIAGEN, Bio-Rad, BD
Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/genomics-market/requestsample.
Core Market Drivers
Growing Adoption of Personalized Medicine
Genomics enables personalized drug therapy based on individual genetic profiles.
Precision treatments improve outcomes for oncology, cardiovascular, metabolic, and neurological disorders.
Technological Advancements in Sequencing
Rapid decline in sequencing costs fuels adoption across clinical diagnostics and research.
NGS platforms enhance speed, accuracy, and scalability of genomic analysis.
Increasing Applications in Drug Discovery
Pharmaceutical companies rely heavily on genomics for identifying molecular targets and biomarkers.
Genomics accelerates drug development timelines and reduces failure rates.
Rising Prevalence of Genetic and Chronic Diseases
High incidence of cancer, rare diseases, and inherited disorders drives demand for genomic testing.
Expanding Bioinformatics and Computational Genomics
AI and machine learning support complex dataset analysis.
Cloud-based platforms improve accessibility and analytical power.
Government and Private Investments
Strong funding initiatives for genomic research, precision medicine, and population genome programs.
Genomics Market Segmentation by Offering
Products
Genomics products contribute the largest share, including instruments, software, reagents, and consumables.
Used in sequencing, PCR, sample preparation, analysis, and validation.
Demand is driven by rising genomics research volume.
Instruments/Systems
NGS platforms
PCR instruments
Microarray scanners
Flow cytometers
These systems form the backbone of genomics laboratories, enabling high-throughput testing.
Software
Bioinformatics platforms
Cloud-based genomic analysis solutions
AI-driven interpretation tools
Software adoption grows with increased data complexity.
Consumables & Reagents
Kits for sequencing, PCR, extraction
Flow cytometry reagents
Microarray reagents
High usage frequency ensures recurring revenue streams.
Services
Genomics services support clinical diagnostics, research, and therapeutic development.
NGS-based Services
Whole genome sequencing
Exome sequencing
Transcriptome sequencing
Core Genomics Services
Gene expression analysis
DNA/RNA extraction
Genotyping
Biomarker Translation Services
Identification of diagnostic and prognostic markers
Companion diagnostics development
Computational Services
Data management
Algorithm-based analysis
Structural and functional genomic modeling
Others
Clinical interpretation services
Genetic counseling
Genomics Market Segmentation by Technology
Sequencing
Sequencing dominates the market due to its critical role in disease diagnosis, genetic profiling, and research.
Whole genome sequencing (WGS)
Targeted sequencing
RNA sequencing
Exome sequencing
PCR
Widely used in molecular diagnostics
Essential for amplification in sequencing and mutation detection
Flow Cytometry
Used for cell analysis in immunology, cancer research, and regenerative medicine
Microarrays
Gene expression profiling
Genotyping
Disease association studies
Others
CRISPR-based technologies
Nanopore sequencing
Single-cell genomics
Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/genomics-market.
Genomics Market Segmentation by Application
Drug Discovery and Development
Genomics accelerates target identification, drug screening, and precision therapy development.
Enables pharmacogenomics
Lowers R&D costs
Functional Genomics
Studies gene functions and interactions to decode biological pathways.
Biomarker Discovery
Critical for early disease detection, monitoring, and treatment selection.
Oncology biomarkers
Neurological biomarkers
Cardiovascular markers
Pathway Analysis
Supports identification of metabolic and signaling pathways linked to diseases.
Epigenomics
Focuses on DNA methylation, histone modification, and gene expression regulation.
Diagnostics
Genomics-based diagnostics are widely adopted for:
Genetic disorders
Infectious diseases
Prenatal testing
Cancer screening
Infectious Diseases
Genomics provides pathogen detection, variant monitoring, and outbreak tracking.
Reproductive Health
Carrier screening
IVF embryo testing
Prenatal screening
Others
Agricultural genomics
Animal genomics
Forensic genomics
Genomics Market Segmentation by End User
Pharmaceutical and Biotechnology Companies
Largest end-user segment
Utilize genomics for drug development and therapeutic innovation
Hospitals and Clinics
Use genomic testing for diagnosis and treatment decisions
Diagnostic Laboratories
High adoption of NGS platforms and bioinformatics software
Academic and Research Institutes
Major contributors to genomic discoveries and clinical research
Others
CROs
Population genomics centers
Government health agencies
Genomics Market Segmentation by Region
North America
Dominates due to strong infrastructure and presence of major players
High investment in precision medicine and cancer genomics
Europe
Strong government funding for genome sequencing initiatives
Rising adoption in clinical and research applications
Asia Pacific
Fastest-growing region
Increasing genomics research in China, Japan, India
Expanding healthcare infrastructure
Latin America
Growing genomic testing for cancer and rare diseases
Middle East and Africa
Emerging genomic programs and improved healthcare access
Competitive Landscape
Key Companies in the Genomics Market
Illumina, Inc.
Thermo Fisher Scientific
Danaher Corporation
F. Hoffmann-La Roche
QIAGEN
Agilent Technologies
Revvity
Charles River Laboratories
Bio-Rad Laboratories
Becton, Dickinson and Company
Strategies Adopted
Product portfolio expansion
Launch of advanced sequencing systems
Collaborations with research institutes
Investments in bioinformatics platforms
Acquisitions to strengthen genomic service offerings
Market Trends
Rise of single-cell genomics for precision research
AI-driven genomic interpretation improving accuracy and speed
Growing consumer genomics market through direct-to-consumer DNA testing
Integration of CRISPR technologies for gene editing innovations
Population-scale genome sequencing for health insights
Market Outlook
The Genomics Market is poised for major advancements as AI, bioinformatics, sequencing platforms, and personalized medicine converge to redefine diagnostics, treatment, and drug development.
By 2034, the market is expected to surpass USD 120.89 Billion, supported by widespread clinical adoption, government investments, and strong demand from pharma and biotech companies.
Browse More Reports
United States Topical Pain Relief Market - https://bit.ly/43Fje4N.
Cough Syrup Market - https://bit.ly/4oRldLU.
Emergency Medical Services (EMS) Vehicle Market - https://bit.ly/3JwPrV9.
India Biosimilar Market - https://bit.ly/4oX4xT4.
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genomics Market to Reach USD 120.89 Bn, Growing at 10.20% CAGR here
News-ID: 4292841 • Views: …
More Releases from Expert Market Research
Generic Injectables Market Set for 7.80% CAGR Rise by 2034
What Is Driving the Growth of the Generic Injectables Market?
The Generic Injectables Market is witnessing significant growth due to increasing healthcare demands, rising prevalence of chronic diseases, and supportive regulatory frameworks promoting generic drug adoption. Valued at USD 56.90 Billion in 2024, the market is projected to reach USD 120.59 Billion by 2034, growing at a CAGR of 7.80% during the forecast period 2025-2034.
Generic injectables are preferred for their affordability,…
Fertility Supplements Market to Reach USD 5.02B by 2034
What Is Driving the Growth of the Fertility Supplements Market?
The Fertility Supplements Market is experiencing significant growth due to increasing awareness about fertility issues, rising infertility rates, and the growing demand for natural and effective nutritional support to improve reproductive health. Valued at USD 2.26 Billion in 2024, the market is projected to reach USD 5.02 Billion by 2034, growing at a CAGR of 8.30% during the forecast period 2025-2034.
Fertility…
Europe Viral Vector Manufacturing Market to Hit USD 15.75B by 2034
What Is Driving the Growth of the Europe Viral Vector Manufacturing Market?
The Europe Viral Vector Manufacturing Market is experiencing rapid growth due to advancements in gene therapy, increasing demand for cell and gene-based therapies, and the rising adoption of viral vectors in vaccine development. Valued at USD 2.60 Billion in 2024, Europe holds a significant share of the global market. The market is projected to reach USD 15.75 Billion by…
Europe Stem Cell Assay Market to Hit USD 22.07B by 2034
What Is Driving the Growth of the Europe Stem Cell Assay Market?
The Europe Stem Cell Assay Market is witnessing robust growth due to advancements in stem cell research, technological innovations in assays, and rising applications in regenerative medicine and drug development. Valued at USD 6.40 Billion in 2024, Europe holds a significant share of the global market. The market is projected to reach USD 22.07 Billion by 2034, growing at…
More Releases for Genomics
Spatial Genomics & Transcriptomics Market to Witness Huge Growth by Key Players: …
The Spatial Genomics & Transcriptomics market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Spatial Genomics & Transcriptomics report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The Spatial Genomics & Transcriptomics research report also provides…
Spatial Genomics and Transcriptomics Market to Witness Huge Growth by Key Player …
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Spatial Genomics and Transcriptomics market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report.
This…
Artificial Intelligence for Genomics and Personalised Medicine Market 2021-28|| …
An artificial neural network can reveal patterns in huge amounts of gene expression data, and discover groups of disease-related genes. Scientists hope that the new method can eventually be applied within precision medicine and individualized treatment.
Similar to diagnosing a disease using a genomic basis, AI can help identify which genes have been affected by harmful mutations so that they can be targeted in gene therapy. DNA repair after editing is…
Artificial Intelligence In Genomics Market have Huge Growth of CAGR 52% By 2021- …
The recent report on the Artificial Intelligence In Genomics market offers a thorough assessment of the business vertical as well as a comprehensive overview of the industry and its key segments. According to the report, the growing technological developments and research advancements are contributing to the market's expansion. The report provides extensive insight into key market elements such as drivers, restraints, challenges, strategic expansions, market size and share, growth prospects,…
AI in Genomics Market Top Manufacturers 2030 Fabric Genomics Inc., Verge Genomic …
Allied Market Research published a latest report titled, “AI in Genomics Market : Global Opportunity Analysis and Industry Forecast 2020-2027’’.
The market report features the factors and top market trends that fuel the growth of the market.
Avail sample report with Industry Insights @
https://www.alliedmarketresearch.com/request-sample/11921
Frontrunners in the AI in Genomics Market:
The report includes the frontrunners in the market including Fabric Genomics Inc., Verge Genomics, Freenome Holdings, Inc., MolecularMatch Inc. These market…
What's Driving the Spatial Genomics Market Growth? 10x Genomics, S2 Genomics, Na …
This Spatial Genomics Market research document is structured with the most excellent and advanced tools of collecting, recording, estimating and analysing market data. A profound knowledge of industrial unanimity, market trends and incredible techniques give client's an upper hand in the ABC industry. Businesses can effectively use the data, statistics, research, and insights about the market included in this Spatial Genomics Market report to make decisions about business strategies and…
